ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 83 filers reported holding ALLOVIR INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,184 | -36.8% | 6,597,167 | 0.0% | 0.61% | -12.5% |
Q2 2023 | $22,430 | +2.1% | 6,597,167 | +18.3% | 0.70% | -46.8% |
Q1 2023 | $21,974 | -23.2% | 5,577,167 | 0.0% | 1.31% | -18.2% |
Q4 2022 | $28,611 | -99.9% | 5,577,167 | 0.0% | 1.60% | -15.0% |
Q3 2022 | $44,004,000 | +385.6% | 5,577,167 | +140.0% | 1.88% | +288.0% |
Q2 2022 | $9,061,000 | -42.2% | 2,323,371 | 0.0% | 0.48% | -26.3% |
Q1 2022 | $15,683,000 | -47.8% | 2,323,371 | 0.0% | 0.66% | -19.5% |
Q4 2021 | $30,064,000 | -48.4% | 2,323,371 | 0.0% | 0.82% | -37.4% |
Q3 2021 | $58,224,000 | +27.0% | 2,323,371 | 0.0% | 1.30% | +40.0% |
Q2 2021 | $45,863,000 | -15.6% | 2,323,371 | 0.0% | 0.93% | -3.1% |
Q1 2021 | $54,367,000 | -39.1% | 2,323,371 | 0.0% | 0.96% | -49.9% |
Q4 2020 | $89,310,000 | +39.8% | 2,323,371 | 0.0% | 1.92% | +23.6% |
Q3 2020 | $63,893,000 | – | 2,323,371 | – | 1.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 2,323,371 | $58,224,000 | 1.30% |
GMT CAPITAL CORP | 476,488 | $11,941,000 | 1.05% |
Woodline Partners LP | 1,459,548 | $36,576,000 | 0.60% |
SECTORAL ASSET MANAGEMENT INC | 263,375 | $6,600,000 | 0.55% |
Redmile Group, LLC | 836,912 | $20,973,000 | 0.37% |
Samsara BioCapital, LLC | 82,336 | $2,063,000 | 0.32% |
Endurant Capital Management LP | 44,430 | $1,113,000 | 0.25% |
AMERICAN INTERNATIONAL GROUP, INC. | 1,145,032 | $28,695,000 | 0.15% |
Virtus ETF Advisers LLC | 9,359 | $235,000 | 0.10% |
Alkeon Capital Management | 1,093,520 | $27,404,000 | 0.05% |